A new avenue for molecular glues: Rapid discovery of a NFKB1 degrader
- PMID: 37084716
- DOI: 10.1016/j.chembiol.2023.04.002
A new avenue for molecular glues: Rapid discovery of a NFKB1 degrader
Abstract
Targeted protein degradation using molecular glues is a powerful method for targeting traditionally undruggable proteins. One challenge in molecular glue discovery is the absence of rational discovery methods. Here, King et al. leverage covalent library screening with chemoproteomics platforms to rapidly discover a molecular glue targeting NFKB1 via UBE2D recruitment.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests FMF is a scientific co-founder and equity holder in Proximity Therapeutics and a scientific advisory board member and equity holder in Triana Biomedicines. Fleur Ferguson is or was recently a consultant or received speaking honoraria from Eli Lilly and Co., RA Capital, Tocris BioTechne, and Plexium Inc. The Ferguson lab receives or has received research funding from Ono Pharmaceutical Co. Ltd and Merck & Co.
Comment on
-
Chemoproteomics-enabled discovery of a covalent molecular glue degrader targeting NF-κB.Cell Chem Biol. 2023 Apr 20;30(4):394-402.e9. doi: 10.1016/j.chembiol.2023.02.008. Epub 2023 Mar 9. Cell Chem Biol. 2023. PMID: 36898369 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
